PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Chart, page-2175

  1. 1,706 Posts.
    lightbulb Created with Sketch. 3231
    You believe that 51 Cap are selling on the cusp of an IND approval and what should be a big re-rate? You think they didn't foresee delays and questions from the FDA? And more passive aggressive accusations about a poster.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.